Junshi Biosciences Announces Phase 3 Study of Toripalimab Combined with Bevacizumab for the First-line Treatment of Advanced Hepatocellular Carcinoma Meets Primary Endpoint
Globe Newswire12-06-2024, 09:06
Meltwater Named to G2 Best Software Awards for Second Year in a Row 10-02-2023, 04:25